MTOR and ovarian cancer: Taking these results of this study together (Figs. 10, 11 and 12), it was reasonable to speculate that UBE2S may promote the malignant progression of ovarian cancer cells by promoting the PI3K/AKT/mTOR signaling pathway and thereby promoting cell cycle and inhibiting apoptosis.